Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Yizhuang Biomedical Mergers and Acquisition Funds

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 3
Lead investments 0
Key employees Soon

Areas of investment

  • Health Diagnostics
  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
Summary

The main department of described VC is located in the Yizhuang. The company was established in Asia in China.

The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2019.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Yizhuang Biomedical Mergers and Acquisition Funds, startups are often financed by Yueyin Venture Capital, Sigma Square Capital, Insight Capital. The meaningful sponsors for the fund in investment in the same round are Sigma Square Capital, Juren Capital, Insight Capital.

Among the most popular fund investment industries, there are Biotechnology, Health Diagnostics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight GenomePrecision. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Yizhuang Biomedical Mergers and Acquisition Funds:
Typical Co-investors
Yizhuang Biomedical Mergers and Acquisition Funds is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Yizhuang Biomedical Mergers and Acquisition Funds:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aju Hotels & Resorts Seoul, Seoul-t'ukpyolsi, South Korea
Dental Investment Group France, Ile-de-France, Paris
ELECNOR Madrid, Madrid, Spain
Futai Touzi China, Guangdong, Shenzhen
Grand Delta Angels Avignon, France, Provence-Alpes-Côte d'Azur
Huiying Investment China, Shaanxi, Xian Shi
Inabata Japan, Osaka, Osaka Prefecture
INEO Capital New York, New York, United States
iTulip Lexington, Massachusetts, United States
Kipo Guatemala, Guatemala City
LG Chem Seoul, Seoul-t'ukpyolsi, South Korea
Multiplier Capital New York, New York, United States
N.XT Northwestern University Evanston, Illinois, United States
OOE Hightechfonds GmbH Austria, Linz, Oberosterreich
Particular Ventures California, San Francisco, United States
Reimann Investors Bayern, Germany, München
Rosewood Corporation Dallas, Texas, United States
SDIC Fund Management Beijing, Beijing, China
Seamless Accelerator Grand Rapids, Michigan, United States
THINK China, Wenzhou, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Green Bamboo Bio

Biopharma
Biotechnology
Health Care
Health Diagnostics
Medical
30 Jun 2022 Beijing, Beijing, China

GenomePrecision

Biotechnology
Health Diagnostics
$15M18 Feb 2019 Dongcheng District, Beijing, China

Health Care
15 May 2018 Dongcheng District, Beijing, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Yizhuang Biomedical Mergers and Acquisition Funds?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 5M
Peak activity year 2022
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Green Bamboo Bio

Biopharma
Biotechnology
Health Care
Health Diagnostics
Medical
30 Jun 2022 Beijing, Beijing, China

GenomePrecision

Biotechnology
Health Diagnostics
$15M18 Feb 2019 Dongcheng District, Beijing, China

Health Care
15 May 2018 Dongcheng District, Beijing, China
Crunchbase icon

Content report

The following text will be sent to our editors: